Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid in Total Knee Arthroplasty
NCT01370460Phase 2Completed
- Sponsor
- Henry Ford Health
- Start
- Jun 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute blood loss anemia comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Blood Loss at 3 days. Started Jun 2011; status: completed.
02
Drugs
tranexamic acid
03
Conditions
acute blood loss anemia
Beyond the preview
Go deeper on NCT01370460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370460.